BridgeMD
New treatment option for Wheezing
Official title PREcision Medicine Directed Corticosteroids In Children With preSchool Wheeze
ClinicalTrials.gov ID: NCT06580600
What this study is testing
- What it's testing
- Young children frequently attend the emergency department (ED) with wheeze which is usually triggered by a virus infection, such as the common cold. Wheeze can be treated with inhaled medications and sometimes oral steroid medicines are also given to reduce swelling within the lungs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 24 to 60. Healthy volunteers may be eligible.
You may be able to join if
- 24-60 months (infants from 24 months +0 days to 60 months + 0 days inclusive)
- Clinical diagnosis of acute wheeze
- Clinical uncertainty regarding the benefit of OCS as part of patient's standard care
You likely can't join if
- Signs and symptoms of severe or life-threatening wheeze
- Patients presenting with wheeze suspicious for a non - respiratory cause
- Clinical evidence of shock or bacterial sepsis
- Past history of severe or life-threatening asthma or history of previous PICU admission with acute wheeze
- History of preterm birth (before 36+0 weeks gestation)
- Known immunodeficiency/ongoing immunosuppressive therapy
See the full eligibility criteria
- 24-60 months (infants from 24 months +0 days to 60 months + 0 days inclusive)
- Clinical diagnosis of acute wheeze
- Clinical uncertainty regarding the benefit of OCS as part of patient's standard care
- Signs and symptoms of severe or life-threatening wheeze
- Patients presenting with wheeze suspicious for a non - respiratory cause
- Clinical evidence of shock or bacterial sepsis
- Past history of severe or life-threatening asthma or history of previous PICU admission with acute wheeze
- History of preterm birth (before 36+0 weeks gestation)
- Known immunodeficiency/ongoing immunosuppressive therapy
- Contraindication to oral corticosteroids
- Previously enrolled in the PRECISE Study
The study team makes the final eligibility decision.
Where it's taking place
- Belfast, NI, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 24 months to 60 months. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Belfast, NI, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.